BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ZT003 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ZT003\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07184502-204@assetmemo.bio
DTSTAMP:20261121T005302Z
DTSTART;VALUE=DATE:20261224
DTEND;VALUE=DATE:20261225
SUMMARY:ZT003: Phase 1 readout est. (NCT07184502)
DESCRIPTION:ZT003\, phase 1.\nStudy: Study to Evaluate the Safety\, Tolerab
 ility\, and Pharmacokinetics of ZT003 Injection Following Single and Multi
 ple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese 
 Volunteers\nEstimated primary completion: 24 December 2026. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/zt003#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07184502
URL:https://assetmemo.bio/drug/zt003#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
